Objective
This is a research and development project, describing a new biotechnology approach to cell replacement therapy for a number of severe diseases, based on genetically modified mesoderm stem cells.
The research will cover all aspects of the problem, including:
1) isolation of stem cells from different tissues and organs,
2) study of their phenotype and basis biology,
3) design and construction of viral vectors for their genetic modification,
4) development of pre-clinical models of disease correction by genetically-modified stem cell transplantation, and
5) products and protocols for phase I/II clinical application.
The research will be carried out by a partnership of six laboratories in four different European countries, which include a start-up biotechnology company with a strategic interest in tissue engineering and gene therapy. The groups are led by top European scientists who pioneered the field and have the highest qualification.
Fields of science
Call for proposal
Data not availableFunding Scheme
CSC - Cost-sharing contractsCoordinator
00185 ROMA
Italy